Menu
Back to User profile » Dr Abdul Sadiq
Papers published by Dr Abdul Sadiq:
Berberine Nanoparticles with Enhanced in vitro Bioavailability: Characterization and Antimicrobial Activity [Retraction]
Sahibzada MUK, Sadiq A, Faidah HS, Khurram M, Amin MU, Haseeb A, Kakar M
Drug Design, Development and Therapy 2024, 18:257-258
Published Date: 2 February 2024
Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability [Retraction]
Rahim H, Sadiq A, Ullah R, Bari A, Amin F, Farooq U, Ullah Jan N, Mahmood HM
International Journal of Nanomedicine 2023, 18:7711-7712
Published Date: 15 December 2023
Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Retraction]
Rahim H, Sadiq A, Khan S, Amin F, Ullah R, Shahat AA, Mahmood HM
International Journal of Nanomedicine 2022, 17:5779-5780
Published Date: 28 November 2022
Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer’s Disease: Synthesis, Characterization, Computational and in vitro Approaches
Zafar R, Naureen H, Zubair M, Shahid K, Saeed Jan M, Akhtar S, Ahmad H, Waseem W, Haider A, Ali S, Tariq M, Sadiq A
Drug Design, Development and Therapy 2021, 15:2679-2694
Published Date: 21 June 2021
Synthesis of Michael Adducts as Key Building Blocks for Potential Analgesic Drugs: In vitro, in vivo and in silico Explorations
Ahmad S, Mahnashi MH, Alyami BA, Alqahtani YS, Ullah F, Ayaz M, Tariq M, Sadiq A, Rashid U
Drug Design, Development and Therapy 2021, 15:1299-1313
Published Date: 23 March 2021
RETRACTED ARTICLE: Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability
Rahim H, Sadiq A, Ullah R, Bari A, Amin F, Farooq U, Ullah Jan N, Mahmood HM
International Journal of Nanomedicine 2020, 15:8999-9009
Published Date: 17 November 2020
Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Corrigendum]
Rahim H, Sadiq A, Khan S, Amin F, Ullah R, Shahat AA, Mahmood HM
International Journal of Nanomedicine 2020, 15:6561-6562
Published Date: 4 September 2020
Comparative Cholinesterase, α-Glucosidase Inhibitory, Antioxidant, Molecular Docking, and Kinetic Studies on Potent Succinimide Derivatives
Ahmad A, Ullah F, Sadiq A, Ayaz M, Saeed Jan M, Shahid M, Wadood A, Mahmood F, Rashid U, Ullah R, Sahibzada MUK, Alqahtani AS, Mahmood HM
Drug Design, Development and Therapy 2020, 14:2165-2178
Published Date: 3 June 2020
Pharmacological Evaluation of Aldehydic-Pyrrolidinedione Against HCT-116, MDA-MB231, NIH/3T3, MCF-7 Cancer Cell Lines, Antioxidant and Enzyme Inhibition Studies
Ahmad A, Ullah F, Sadiq A, Ayaz M, Rahim H, Rashid U, Ahmad S, Jan MS, Ullah R, Shahat AA, Mahmood HM
Drug Design, Development and Therapy 2019, 13:4185-4194
Published Date: 10 December 2019
RETRACTED ARTICLE: Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition
Rahim H, Sadiq A, Khan S, Amin F, Ullah R, Shahat AA, Mahmood HM
International Journal of Nanomedicine 2019, 14:6287-6296
Published Date: 6 August 2019
RETRACTED ARTICLE: Berberine nanoparticles with enhanced in vitro bioavailability: characterization and antimicrobial activity
Sahibzada MUK, Sadiq A, Faidah HS, Khurram M, Amin MU, Haseeb A, Kakar M
Drug Design, Development and Therapy 2018, 12:303-312
Published Date: 14 February 2018
Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies
Rahim H, Sadiq A, Khan S, Khan MA, Shah SMH, Hussain Z, Ullah R, Shahat AA, Ibrahim K
Drug Design, Development and Therapy 2017, 11:2443-2452
Published Date: 23 August 2017
Fabrication, characterization and in vitro evaluation of silibinin nanoparticles: an attempt to enhance its oral bioavailability
Sahibzada MUK, Sadiq A, Khan S, Faidah HS, Naseemullah, Khurram M, Amin MU, Haseeb A
Drug Design, Development and Therapy 2017, 11:1453-1464
Published Date: 15 May 2017